Sweden· SE-20240816000021
Ezmekly 2 mg Kapsel, hård
A medicinal product containing mirdametinib, registered in Sweden by Merck Europe B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Mirdametinib
- Manufacturer
- Merck Europe B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240816000021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirdametinib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGomekliSpringWorks Therapeutics, Inc.
- CzechiaEZMEKLYMerck Europe B.V., Amsterdam
- SwitzerlandEzmekly
- BelgiumEzmekly 2 mgMerck Europe
- IcelandEzmeklyMerck Europe B.V.*
- NetherlandsEzmekly 2 mg harde capsulesMerck Europe B.V.
- NorwayEzmeklyMerck Europe B.V.
- PolandEzmeklySpringWorks Therapeutics Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ezmekly
- Liechtenstein · Ezmekly
- Norway · Ezmekly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/86adfc76-7216-45fa-9d96-b9038449b84a GET /v1/drugs/86adfc76-7216-45fa-9d96-b9038449b84a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"Dispensbeslut",
"EPAR",
"EMA"
],
"se_npl_id": "20240816000021",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240816000021",
"product_doc_link": "https://docetp.mpa.se/LMF/Ezmekly%2C%20burk%2042%20kapslar%2C%20sammanfattning%20av%20beslut%2C%20giltigt%20fr.o.m.%202026-06-17%20t.o.m.%202026-12-31%20%282%20mg%29_09001bee85158592.pdf"
}See everything about mirdametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.